U.S. Diversified Financial Stock News

Strive Asset Management (ASST) has drawn investor attention after recent trading, with the stock last closing at US$0.86. Short term moves contrast with weaker returns over the past 3 months, prompting closer scrutiny of fundamentals. See our latest analysis for Strive Asset Management. The 1 day share price return of 17.15% and 7 day share price return of 11.79% sit against a 90 day share price return decline of 58.83%, suggesting short term momentum is building after a weak few months...

Recent commentary around Pool (POOL) has focused on cooling demand as household budgets tighten. This has raised questions about how the pool supplier can reinvigorate growth when roughly 95% of its revenue still depends on North American customers. See our latest analysis for Pool. Pool’s share price has softened in recent months, with a 90 day share price return of 23.71% and a 1 year total shareholder return of 29.78%. This suggests momentum has faded as investors reassess growth and risk...

If you are wondering whether Garmin's current share price lines up with its underlying worth, this article is designed to walk you through the pieces that matter most. Garmin's share price closed at US$202.44, with a 1.5% decline over the last 7 days, a 0.6% decline over the last 30 days, and a 1% decline over the last year. The 3 year and 5 year returns are 118.9% and 86.1% respectively, and the year to date return sits at 0.0%. Those moves have put valuation questions back on the radar for...

ResMed (RMD) is back in focus as the company approaches its fiscal second quarter 2026 earnings release, with analysts watching closely after several quarters of topping Wall Street earnings expectations. See our latest analysis for ResMed. At a latest share price of $244.81, ResMed’s 90 day share price return of a 13.58% decline contrasts with a 1 year total shareholder return of 5.06% and a 3 year total shareholder return of 20.05%. This suggests recent momentum has faded even as longer...

In December 2025, Kroger completed a major share repurchase phase, buying back about 14.2% of its stock for roughly US$6.60 billion, and on December 23, 2025, the company lifted its total buyback authorization to about US$9.50 billion. This sizable increase in repurchase capacity highlights Kroger’s ongoing commitment to returning cash to shareholders while it reshapes its e-commerce and fulfillment model. We’ll now explore how Kroger’s expanded buyback authorization and continued...

Morgan Stanley previously lowered its rating on BorgWarner to Equal Weight while the company simultaneously raised its 2025 financial performance estimates, citing higher industrial production and favorable foreign exchange despite ongoing production delays in North America and Europe. The combination of a cautious outlook for electric vehicles through 2026 and management’s improved near-term guidance highlights BorgWarner’s reliance on internal combustion and hybrid powertrains as a key...

Recently, Raymond James cut its rating on Hess Midstream from Outperform to Market Perform, citing limited near-term growth prospects, while the company also reshaped its board after director Andrew B. Walz resigned to become an executive officer at Chevron. This combination of a cooler analyst view and governance changes tied to Chevron’s influence raises fresh questions about Hess Midstream’s medium-term growth path and independence. Next, we’ll examine how Raymond James’ downgrade,...

Cal-Maine Foods (CALM) has recently drawn attention after a period of weaker share performance, with the stock down over the past week, month, past 3 months and year. This has prompted investors to reassess its current valuation. See our latest analysis for Cal-Maine Foods. The recent 4.4% 7 day share price decline and 15.5% 3 month share price pullback come against a 1 year total shareholder return of an 18.2% decline, but a much stronger 3 and 5 year total shareholder return. This suggests...

RenaissanceRe Holdings (NYSE:RNR) is back on investors’ radar after recent share price moves, with the stock closing at US$272.24. That puts its 1 year total return at 10.2% and its past 3 months performance at 2.0%. See our latest analysis for RenaissanceRe Holdings. Recent trading has been a bit choppy, with a 1 day share price return of 3.17% decline and a 7 day share price return of 4.09% decline. That sits against a 1 year total shareholder return of 10.2% and a 5 year total shareholder...

In recent days, SkyWater Technology reported strong performance from its newly acquired Texas operation and guided fourth-quarter revenue to a US$155 million–US$165 million range, ahead of its February earnings release. An important angle for investors is how this Texas facility appears to be contributing meaningfully to near-term revenue visibility and operational scale. We’ll now examine how the stronger-than-expected contribution from the Texas acquisition could influence SkyWater...

Recent analyst commentary around Sherwin-Williams (SHW) has highlighted the company’s pricing power, brand strength, and cost discipline, with investors now looking to the upcoming earnings release as a key test of those themes. See our latest analysis for Sherwin-Williams. At a share price of $327.84, Sherwin-Williams has seen short term share price returns move slightly in both directions recently, while its 3 year total shareholder return of 42.72% contrasts with a slightly negative 1 year...

In Q3 2025, Sunrun Inc. reported a revenue increase of 35% year over year, a 10% rise in aggregate subscriber value, strong storage adoption, and six consecutive quarters of positive cash flow, supported by US$709 million in unrestricted cash and ongoing access to capital markets. This combination of improving cash generation and storage-led unit economics has strengthened the perception of Sunrun’s business model resilience and long-term value creation potential. Next, we’ll examine how...

Why Coca-Cola stock is on investors’ radar today Coca-Cola (KO) is back in focus after recent trading left the shares with a 1.1% one day decline and slightly lower performance over the past week and month, despite a positive past 3 months. See our latest analysis for Coca-Cola. Zooming out, Coca-Cola’s recent share price softness contrasts with a 1-year total shareholder return of 17.0% and a 5-year total shareholder return of 60.0%. This suggests longer term momentum remains positive even...

Mirion Technologies (MIR) has drawn fresh attention after reporting quarterly earnings per share ahead of expectations, along with strong performance in its nuclear power end market, yet the stock has retreated following the announcement. See our latest analysis for Mirion Technologies. The latest earnings news arrives after a mixed stretch in the share price, with a 3.03% 90 day share price return and a 36.25% 1 year total shareholder return suggesting long term momentum, while shorter term...

Radian Group (RDN) is back on investors’ radar after recent share price moves. The stock last closed at $35.92, prompting fresh questions about how its mortgage and real estate services business is currently valued. See our latest analysis for Radian Group. While the latest move to $35.92 comes with a modest 1-day share price return of 0.19% decline and a 7-day share price return of 0.99% decline, the share price return over the last 30 and 90 days has been positive. Over the longer term,...

Mineralys Therapeutics recently advanced its aldosterone synthase inhibitor program as the Phase 3 Launch-HTN trial of Lorundrostat, which showed significant reductions in systolic blood pressure in treatment-resistant hypertension, was recognized in JAMA’s inaugural “Research of the Year,” and the company received FDA pre-NDA feedback supporting a planned New Drug Application submission. This recognition, combined with the prospect of additional Lorundrostat trial readouts expected in 2026,...

Delcath Systems recently reported publication of subgroup analyses from its phase 3 FOCUS study of the HEPZATO KIT for unresectable metastatic uveal melanoma in the Journal of Cancer Research and Clinical Oncology, detailing efficacy and safety outcomes across multiple patient categories. The data highlight that patients with lower tumor burden and low or normal LDH experienced meaningfully longer progression-free and overall survival, with many responses emerging only after several...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 19x, you may...

Today we're going to take a look at the well-established Costco Wholesale Corporation ( NASDAQ:COST ). The company's...

The fact that multiple The Coca-Cola Company ( NYSE:KO ) insiders offloaded a considerable amount of shares over the...

Event driven move in Intuitive Machines stock Intuitive Machines (LUNR) has drawn fresh attention after recent trading saw the share price close at US$17.88, with short term returns over the past week and month outpacing its past year performance. See our latest analysis for Intuitive Machines. The recent move to a US$17.88 share price comes after a sharp 30 day share price return of 59.5% and a 90 day share price return of 51.65%, set against a 1 year total shareholder return decline of...

Apollo Global Management (APO) is back in focus after recent trading, with the share price last closing at $146.61. For investors, the key questions now center on returns, earnings trends, and valuation. See our latest analysis for Apollo Global Management. Recent trading has been choppy, with a 1-day share price return of 1.28% and a 30-day share price return of 6.14%. However, the 1-year total shareholder return shows a decline of 12.08%, which contrasts with a very large 3-year total...